Associated British Foods may break off its fashion business from its unit that makes tea bags and sugar. A split makes sense, ...
The US coffee giant is selling control of its mainland retail operations to Boyu Capital in a $4 bln deal, even though it ...
The Spanish group’s new plan involves a 50% dividend cut to trim leverage and fund investments. Yet its targets are modest, and the upside from M&A and a cybersecurity push is still uncertain. A 10% ...
The US private capital group is paying $6 bln for half of the Danish group's big UK renewables project. Orsted gets cash to help avert a credit downgrade. But Apollo’s right to 70% of the wind farm's ...
Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent return to numb the pain of a high price. It’s an opportunistic bet that claims ...
The US pharma giant wants a court to stop biotech Metsera from ditching its deal for an $8.5 bln rival bid from Novo Nordisk. The Danish giant's cash comes with few strings, making the legal approach ...
Izzy Englander sold 15% of his sprawling hedge fund at a $14 bln valuation. With $79 bln in assets, that price implies slower growth even as the industry raises record sums of capital. The architect ...
Brussels wants to coordinate a defensive shield of unmanned aerial vehicles by 2027. Its approach is bureaucratic and slow. A ...
CEO Simon Trott still has time to intervene in his London-listed rival's nil-premium offer for the $21 bln Canadian miner. Stepping in with a higher bid may work, and the returns could stack up. A ...
Welcome back! Donald Trump rated his summit with Xi Jinping a “12 out of 10”. We gave it a lower score. The confab produced an uneasy truce which did not resolve any of the tensions between the ...
A year after the bloc hiked EV import tariffs, Chinese automakers have nearly doubled overall sales there. Next, brands from BYD to Xiaomi will take aim at the premium segment. Fresh tech and ...
The activist shareholder helped the UK insurer deliver cost cuts and release capital. Axa CEO Thomas Buberl has a similar ...